Dashboard
Manage Tickers

CSTL CASTLE BIOSCIENCES INC

Nasdaq castlebiosciences.com


$ 24.82 $ 0.00 (0 %)    

Friday, 24-Oct-2025 07:17:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.54 $ 0.00 (0 %)
DIA $ 468.11 $ 0.00 (0 %)
SPY $ 673.89 $ 0.00 (0 %)
TLT $ 91.28 $ 0.00 (0 %)
GLD $ 373.83 $ 0.00 (0 %)
$ 24.18
$ 23.66
$ 22.20 x 10
$ 24.60 x 450
-- - --
$ 14.59 - $ 35.84
209,403
na
701.42M
$ 1.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-04-2024 09-30-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-10-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 09-03-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

decisiondx-melanoma-validated-across-cutaneous-melanoma-subtypes-in-13560-patients-with-results-to-be-presented-by-castle-biosciences-at-dermatology-conference
DecisionDx-Melanoma Validated Across Cutan...
10/24/2025 08:16:15

This new histological subtype data confirms DecisionDx-Melanoma's clinical value across the spectrum of melanomaCastle Bios...

castle-biosciences-study-finds-15-of-barretts-esophagus-patients-face-higher-cancer-risk-than-pathology-suggests
Castle Biosciences Study Finds 15% of Barr...
09/09/2025 11:19:01

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today anno...

castle-biosciences-expands-decisiondx-scc-test-to-predict-local-recurrence-in-high-risk-skin-cancer-patients
Castle Biosciences Expands DecisionDx-SCC ...
08/25/2025 11:14:27

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today anno...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 17:06:56

sterling-infrastructure-posts-better-than-expected-earnings-joins-lemonade-digitalocean-holdings-lattice-semiconductor-and-other-big-stocks-moving-higher-on-tuesday
Sterling Infrastructure Posts Better-Than-...
08/05/2025 14:43:02

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 12:08:30

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/04/2025 21:07:07

castle-biosciences-raises-fy2025-sales-guidance-from-28700m-29700m-to-31000m-32000m-vs-29410m-est
Castle Biosciences Raises FY2025 Sales Gui...
08/04/2025 20:07:41

Castle Biosciences (NASDAQ:CSTL) raises FY2025 sales outlook from $287.00 million-$297.00 million to $310.00 million-$320.00 mi...

castle-biosciences-q2-adj-eps-015-beats-049-estimate-sales-8619m-beat-7153m-estimate
Castle Biosciences Q2 Adj. EPS $0.15 Beats...
08/04/2025 20:07:18

Castle Biosciences (NASDAQ:CSTL) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 4, 2025
08/04/2025 08:32:29

examining-the-future-castle-biosciencess-earnings-outlook
Examining the Future: Castle Biosciences's...
08/01/2025 19:06:30

castle-biosciences-decisiondx-melanoma-test-granted-breakthrough-device-designation-by-fda
Castle Biosciences' DecisionDx-Melanoma Te...
07/23/2025 11:04:39

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today anno...

castle-biosciences-signs-collaboration-and-license-agreement-with-scibase-to-develop-atopic-dermatitis-flare-prediction-test-using-electrical-impedance-spectroscopy-technology
Castle Biosciences Signs Collaboration And...
06/16/2025 20:32:11

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today anno...

castle-biosciences-announces-it-will-present-research-aimed-at-enhancing-the-clinical-management-of-patients-with-cutaneous-melanoma-and-uveal-melanoma-at-the-2025-american-society-of-clinical-oncology-annual-meeting
Castle Biosciences Announces It Will Prese...
05/29/2025 20:40:46

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, will prese...

scotiabank-maintains-sector-outperform-on-castle-biosciences-lowers-price-target-to-40
Scotiabank Maintains Sector Outperform on ...
05/21/2025 15:50:55

Scotiabank analyst Sung Ji Nam maintains Castle Biosciences (NASDAQ:CSTL) with a Sector Outperform and lowers the price targ...

castle-biosciences-unveils-real-world-data-supporting-prame-integration-to-enhance-uveal-melanoma-risk-prediction
Castle Biosciences Unveils Real-World Data...
05/09/2025 11:06:52

lake-street-maintains-buy-on-castle-biosciences-lowers-price-target-to-35
Lake Street Maintains Buy on Castle Biosci...
05/06/2025 23:14:04

Lake Street analyst Thomas Flaten maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and lowers the price target from $40...

nike-to-70-here-are-10-top-analyst-forecasts-for-tuesday
Nike To $70? Here Are 10 Top Analyst Forec...
05/06/2025 13:13:12

ichor-holdings-posts-weak-earnings-joins-fabrinet-vertex-pharmaceuticals-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Ichor Holdings Posts Weak Earnings, Joins ...
05/06/2025 12:08:19

canaccord-genuity-maintains-buy-on-castle-biosciences-lowers-price-target-to-37
Canaccord Genuity Maintains Buy on Castle ...
05/06/2025 11:32:52

Canaccord Genuity analyst Kyle Mikson maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and lowers the price target from...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION